Where to Watch
Where To Watch
MindMed Invests $5 Million in NYU Langone for Psychedelic Research Center
Oct 8, 2020 02:44 pm
Psychedelic medicine company MindMed is investing $5 million in a new research center. J.R Rahn, co-founder and co-CEO of MindMed, discusses the investment and plans to hit the markets.
MindMed Goes Public on Nasdaq, Looks Ahead to Future of Psychedelics in Health Sector
Psychedelics Medicine Company MindMed Makes Nasdaq Debut
More Than 600 Brands Come Together to Empower People to Take Action for 'Mental Health Action Day' on May 20
Teachers Union President Randi Weingarten on Addressing Family Needs to Fully Reopen Schools
Terms of Service
Follow us on
© 2021 Cheddar, Inc.